BeOne Medicines Ltd. 10-Q filing
Filed 2026-05-06 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001628280-26-030867
- Form type
- 10-Q
- CIK
- 0001651308
- Primary document
- https://www.sec.gov/Archives/edgar/data/1651308/000162828026030867/bgne-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BeOne Medicines Ltd..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $1.5B | - | - |
| Gross Profit | $1.3B | - | - |
| Operating Income | $249.9M | - | - |
| Net Income | $227.4M | - | - |
| Eps Basic | 0.16 | - | - |
| Eps Diluted | 0.15 | - | - |
| Cash And Equivalents | $4.8B | - | - |
| Total Assets | $8.6B | - | - |
| Total Liabilities | $3.8B | - | - |
| Shareholders Equity | $4.8B | - | - |
| Operating Cash Flow | $201.3M | - | - |
| Capital Expenditures | $40.8M | - | - |